Thierry H. LeJemtel

20.3k total citations · 3 hit papers
178 papers, 12.4k citations indexed

About

Thierry H. LeJemtel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Thierry H. LeJemtel has authored 178 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Cardiology and Cardiovascular Medicine, 36 papers in Surgery and 33 papers in Complementary and alternative medicine. Recurrent topics in Thierry H. LeJemtel's work include Heart Failure Treatment and Management (68 papers), Cardiovascular Function and Risk Factors (59 papers) and Cardiovascular and exercise physiology (33 papers). Thierry H. LeJemtel is often cited by papers focused on Heart Failure Treatment and Management (68 papers), Cardiovascular Function and Risk Factors (59 papers) and Cardiovascular and exercise physiology (33 papers). Thierry H. LeJemtel collaborates with scholars based in United States, France and Canada. Thierry H. LeJemtel's co-authors include Edmund H. Sonnenblick, William T. Abraham, Darlene P. Horton, Robert Berkowitz, Kirkwood F. Adams, Gregg C. Fonarow, Maria Rosa Costanzo, Stuart D. Katz, Carol S. Maskin and Marie Galvao and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Thierry H. LeJemtel

174 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

2005 1.6k citations Thierry H. LeJemtel et al. profile →
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure

2000 669 citations Wilson S. Colucci, Robert C. Bourge et al. profile →
In-Hospital Mortality in Patients With Acute Decompensated Heart Failure Requiring Intravenous Vasoactive Medications

2005 500 citations Thierry H. LeJemtel et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thierry H. LeJemtel United States	54	9.9k	2.5k	2.2k	1.8k	1.4k	178	12.4k
Marc A. Silver United States	36	8.1k 0.8×	2.3k 0.9×	1.7k 0.8×	1.3k 0.8×	503 0.3×	148	10.7k
Alain Cohen‐Solal France	61	11.0k 1.1×	1.7k 0.7×	1.1k 0.5×	1.9k 1.1×	1.8k 1.2×	250	13.7k
William W. Parmley United States	68	11.8k 1.2×	3.9k 1.5×	1.6k 0.8×	1.1k 0.7×	1.0k 0.7×	343	15.9k
Mihai Gheorghiade United States	63	13.5k 1.4×	2.1k 0.8×	1.4k 0.7×	3.5k 2.0×	590 0.4×	205	16.7k
John Parissis Greece	53	7.8k 0.8×	1.8k 0.7×	1.7k 0.8×	1.5k 0.8×	510 0.4×	348	11.6k
Michael M. Givertz United States	52	10.5k 1.1×	3.6k 1.4×	2.3k 1.1×	2.4k 1.4×	439 0.3×	180	14.8k
H. Just Germany	49	8.6k 0.9×	1.9k 0.8×	813 0.4×	1.6k 0.9×	818 0.6×	170	11.4k
Dean T. Mason United States	60	9.5k 1.0×	3.8k 1.5×	1.1k 0.5×	1.6k 0.9×	1.4k 1.0×	441	13.4k
Robert Cody United States	43	13.0k 1.3×	2.9k 1.1×	1.0k 0.5×	3.3k 1.9×	812 0.6×	153	17.4k
Piergiuseppe Agostoni Italy	52	6.2k 0.6×	1.4k 0.5×	1.2k 0.6×	2.9k 1.7×	2.7k 1.9×	458	9.8k

Countries citing papers authored by Thierry H. LeJemtel

Since Specialization

Citations

This map shows the geographic impact of Thierry H. LeJemtel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry H. LeJemtel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry H. LeJemtel more than expected).

Fields of papers citing papers by Thierry H. LeJemtel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry H. LeJemtel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry H. LeJemtel. The network helps show where Thierry H. LeJemtel may publish in the future.

Co-authorship network of co-authors of Thierry H. LeJemtel

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry H. LeJemtel. A scholar is included among the top collaborators of Thierry H. LeJemtel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry H. LeJemtel. Thierry H. LeJemtel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samson, Rohan, et al.. (2020). BARIATRIC SURGERY AND HOSPITALIZATION FOR HEART FAILURE IN MORBIDLY OBESE PATIENTS. Journal of the American College of Cardiology. 75(11). 794–794. 2 indexed citations

Onat, Duygu, Serge Cremers, Ante Harxhi, et al.. (2014). Abstract 14812: Acute Venous Congestion Enhances Vasoconstriction, Inflammation, Oxidative stress and Endothelial Activation and in Compensated Ambulatory Patients with Systolic Heart Failure on Stable Medical Regimen. Circulation. 130. 1 indexed citations

Ennezat, Pierre Vladimir, et al.. (2011). Imagine how many lives you save: angiotensin-converting enzyme inhibition for atherosclerotic vascular disease in the present era of risk reduction. Expert Opinion on Pharmacotherapy. 12(6). 883–897. 6 indexed citations

Lund, Lars H., et al.. (2010). Leptin Resistance After Heart Transplantation. European Journal of Heart Failure. 12(5). 516–520. 6 indexed citations

Maréchaux, Sylvestre, Philippe Asseman, Thierry H. LeJemtel, et al.. (2010). Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Archives of cardiovascular diseases. 103(4). 227–235. 30 indexed citations

Lund, Lars H., et al.. (2009). Ghrelin Resistance Occurs in Severe Heart Failure and Resolves After Heart Transplantation. European Journal of Heart Failure. 11(8). 789–794. 34 indexed citations

Lund, Lars H., et al.. (2009). Growth Hormone Resistance in Severe Heart Failure Resolves After Cardiac Transplantation. European Journal of Heart Failure. 11(5). 525–528. 19 indexed citations

Jelić, Sanja, Margherita Padeletti, Steven M. Kawut, et al.. (2008). Inflammation, Oxidative Stress, and Repair Capacity of the Vascular Endothelium in Obstructive Sleep Apnea. Circulation. 117(17). 2270–2278. 467 indexed citations

Sleeper, Lynn A., Prakash Krishnan, Michael H. Picard, et al.. (2005). Functional Status and Quality of Life After Emergency Revascularization for Cardiogenic Shock Complicating Acute Myocardial Infarction. Journal of the American College of Cardiology. 46(2). 266–273. 56 indexed citations

10.

Hochman, Judith S., Christopher E. Buller, Lynn A. Sleeper, et al.. (2000). Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 36(3). 1063–1070. 450 indexed citations

11.

Menon, Venu, Harvey D. White, Thierry H. LeJemtel, et al.. (2000). The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 36(3). 1071–1076. 82 indexed citations

12.

Lowes, Brian D., Michael B. Higginbotham, Marcus A. DeWood, et al.. (2000). Low-dose enoximone improves exercise capacity in chronic heart failure∗∗A list of the Enoximone Study Group Members and institutional affiliations is provided in the appendix.. Journal of the American College of Cardiology. 36(2). 501–508. 37 indexed citations

13.

LeJemtel, Thierry H., et al.. (1998). Recombinant human B-type natriuretic peptide improves symptoms and hemodynamics in patients with acutely decompensated CHF. Journal of the American College of Cardiology. 31. 83–83. 6 indexed citations

14.

Col, J., J Boland, J. Dens, et al.. (1996). Determinants of mortality when primary LV failure complicates acute myocardial infarction. Intensive Care Medicine. 22(S1). S89–S89.

15.

Dickstein, Kenneth, Sidney O. Gottlieb, Eckart Fleck, et al.. (1994). Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.. PubMed. 12(2). S31–5. 37 indexed citations

16.

Jondeau, Guillaume, Stuart D. Katz, Jean‐François Toussaint, et al.. (1993). Regional specificity of peak hyperemic responses in patients with congestive heart failure: Correlation with peak aerobic capacity. Journal of the American College of Cardiology. 22(5). 1399–1402. 54 indexed citations

17.

Liang, Chang‐seng, Douglas K. Stewart, Thierry H. LeJemtel, et al.. (1992). Characteristics of peak aerobic capacity in symptomatic and asymptomatic subjects with left ventricular dysfunction☆. The American Journal of Cardiology. 69(14). 1207–1211. 26 indexed citations

18.

Uretsky, Barry F., James A. Shaver, Chang‐seng Liang, et al.. (1989). Lisinopril for severe congestive heart failure. The American Journal of Cardiology. 63(8). D8–D11. 2 indexed citations

19.

Sonnenblick, Edmund H. & Thierry H. LeJemtel. (1989). Pathophysiology of congestive heart failure. The American Journal of Medicine. 87(6). 88S–91S. 11 indexed citations

20.

Maskin, Carol S., et al.. (1981). Failure of dobutamine to increase peak aerobic power despite hemodynamic improvement in severe heart failure. 82. 308. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact